April 24, 2025 – OrthoSpineNews – Foot Innovate is excited to announce a new corporate partnership with Enovis™ Foot & Ankle, further expanding its growing network of industry collaborations. Enovis™ (NYSE: ENOV), a global medical technology innovator, is committed to advancing clinical outcomes through a high-tech, evidence-based foot and ankle portfolio—designed to meet the evolving needs of surgeons, optimize time in the OR, and support continuous learning through education and hands-on training.
This partnership brings Enovis Foot & Ankle’s comprehensive range of cutting-edge products to the Foot Innovate platform, offering greater access to reconstruction, minimally invasive surgery (MIS) technologies, and core products that support enhanced patient care. Featured products include the DynaNail® TTC and DynaNail Helix™ systems, designed for TTC and hindfoot fusion with sustained dynamic compression technology; the Pecaplasty® system for percutaneous bunion correction; Tarsoplasty, a percutaneous Lapidus correction solution; and the EF1 External Fixation product line, known for its flexible fixation solutions across various foot and ankle surgeries.
“Working with Foot Innovate reflects a shared commitment to Redefining Every Step in foot and ankle care,” said Gary Justak, President and General Manager of Enovis Foot & Ankle. “By combining their trusted educational platform with technologies that deliver results and training that builds confidence, we’re elevating the experience for today’s surgeons. This is exactly the kind of strategic collaboration we believe in—partnerships that go beyond the product to drive impact.”
Foot Innovate’s partnership with Enovis Foot & Ankle underscores its commitment to delivering top-tier educational content to the global foot and ankle medical community —fostering growth and innovation in this specialized field. Sign up for a complimentary Foot Innovate account to access Enovis Foot & Ankle content, upcoming live webinars, and more.
About Enovis:
Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company’s shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV. For more information about Enovis, please visit www.enovis.com.
About Foot Innovate:
Foot Innovate (www.footinnovate.com) is a premier online platform developed by surgeons to meet the educational needs of medical professionals. As the leading resource for foot and ankle education, Foot Innovate provides access to the latest surgical techniques, medical devices, and treatment protocols through its members, contributors, and corporate partners. Our mission is to support healthcare professionals worldwide in advancing their clinical knowledge and expertise.
Contact:
Beverly Williams
Email: bwilliams@footinnovate.com
